National Institutes of Health (NIH): Innovative Measures of Oral Medication Adherence for HIV Treatment and Prevention (R01)

This opportunity uses the R01 Research Project Grant funding mechanism.

This award solicits innovative research applications that seek to advance the development of bioanalytical assays, pill ingestion sensors, drug metabolite and taggant detection systems, or wireless technologic approaches for monitoring and improving adherence to oral antiretroviral therapy (ART) and pre-exposure prophylaxis (PrEP).

Funding & Duration

An estimated total of US $7 million will be allocated to fund 6-8 awards. Application budgets are not limited but need to reflect the actual needs of the proposed project. The project period can be 3-5 years.


Non-domestic (non-U.S.) Entities (Foreign Institutions) are eligible to apply.

Submission Requirements & Due Dates

  • 25 Feb 2015  – Letter of Intent (LOI) via Grants.Gov submission portal.
  • Copy of LOI forwarded to the Research Branch ASAP.
  • 11 Mar 2015 – full applications submitted to the Research Branch for internal review.

Grants Officer: Dr Don McMaster


Further Information

This entry was posted in Funding by Award Type, Grants (Project Funds), Health & Medical Sciences, International Funding and tagged . Bookmark the permalink.

Comments are closed.